EB Research Partnership Australia raises funds to invest in innovative research across the globe to cure Epidermolysis Bullosa as quickly and efficiently as possible.

EB Research Partnership and EB Research Partnership Australia, both non-profit organisations, seeks to award financial grants for global research with the potential to lead directly to commercially feasible products and therapies for treating and/or curing Epidermolysis Bullosa (EB). Applications are processed and managed by EB Research Partnership (USA). Applicants are invited to submit a Letter of Interest (LOI) which will be evaluated and scored by the Scientific Advisory Board (SAB). Based on the SAB’s evaluation and scoring of LOIs and other criteria, EBRP will select specific projects for funding which show a high degree of promise.